Epidemiology of meningococcal disease in the Panamanian pediatric population, 1998-2008

Journal of Infection in Developing Countries

Volumn 5, Issue 5, 2011, Pages 318-323

  Nieto Guevara, Javier ^a   Luciani, Kathia ^b   Montesdeoca Melián, Abian ^c   Mateos Durán, Mercedes ^c  

^a Instituto Conmemorativo Gorgas de Estudios de la Salud   (Panama)

^b Hospital del Nino   (Panama)

^c HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Children; Epidemiology; Neisseria meningitidis; Panama; Serogroup

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; MEROPENEM; PENICILLIN G; QUINOLONE DERIVATIVE;

ADOLESCENT; AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CEREBROSPINAL FLUID CULTURE; CHILD; CLINICAL ARTICLE; FATALITY; FEMALE; GRAM STAINING; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LATEX AGGLUTINATION TEST; MALE; MENINGITIS; MENINGOCOCCEMIA; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PANAMA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD;

NEISSERIA MENINGITIDIS;

EID: 79958101247     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1518     Document Type: Article

References (26)

1. Harrison LH, Trotter CL, Ramsay ME (2009) Global epidemiology of meningococcal disease. Vaccine 27 Suppl 2: B51-63.
2. Caugant DA and Maiden MC (2009) Meningococcal carriage and disease--population biology and evolution. Vaccine 27 Suppl 2: B64-70.
3. Safadi MA and Cintra OA (2010) Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol Res 32: 263-271.
4. Gabastou JM, Agudelo CI, Brandileone MC, Castaneda E, de Lemos AP, and Grupo de Laboratorio de SIREVA II (2008) Characterization of invasive isolates of S. pneumoniae, H. influenzae, and N. meningitidis in Latin America and the Caribbean: SIREVA II, 2000-2005. Rev Panam Salud Publica 24: 1-15.
5. Halperin SA, Gupta A, Jeanfreau R, Klein NP, Reisinger K, Walter E, Bedell L, Gill C, Dull PM (2010) Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age. Vaccine 28: 7865-7867.
6. Poland GA (2010) Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Clin Infect Dis 50 Suppl 2: S45-53.
7. Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME (2004) Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364: 365-367.
8. Martinez AI, Dominguez A, Oviedo M, Minguell S, Jansa JM, Codina G, Vázquez JA; Grupo de Trabajo sobre Enfermedad Meningocócica de Cataluña (2009) Epidemiology of the meningococcal disease in Catalonia before and after vaccination against serogroup C. Rev Esp Salud Publica 83: 725-735.
9. White CP and Scott J (2010) Meningococcal serogroup C conjugate vaccination in Canada: how far have we progressed? How far do we have to go? Can J Public Health 101: 12-14.
10. Wu HM, Harcourt BH, Hatcher CP, Wei SC, Novak RT, Wang X, Juni BA, Glennen A, Boxrud DJ, Rainbow J, Schmink S, Mair RD, Theodore MJ, Sander MA, Miller TK, Kruger K, Cohn AC, Clark TA, Messonnier NE, Mayer LW, Lynfield R (2009) Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N Engl J Med 360: 886-892.
11. Arguedas A, Sher L, Lopez E, Saez-Llorens X, Hamed K, Skuba K, Pierce PF (2003) Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure. Pediatr Infect Dis J 22: 949-956.
12. Levy C, de La Rocque F, Cohen R (2009) [Epidemiology of pediatric bacterial meningitis in France]. Med Mal Infect 39: 419-431.
13. Taha MK, Zarantonelli ML, Neri A, Enriquez R, Vazquez JA, Stefanelli P (2006) Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis. Antimicrob Agents Chemother 50: 887-892.
14. Pastor P, Medley FB, Murphy TV (2000) Meningococcal disease in Dallas County, Texas: results of a six-year population-based study. Pediatr Infect Dis J 19: 324-328.
15. Kaplan SL, Schutze GE, Leake JA, Barson WJ, Halasa NB, Byington CL, Woods CR, Tan TQ, Hoffman JA, Wald ER, Edwards KM, Mason EO Jr (2006) Multicenter surveillance of invasive meningococcal infections in children. Pediatrics 118: e979-984.
16. Tuan PL, Li WC, Huang YC, Chiu CH, Lin TY (2009) Invasive pediatric Neisseria meningitidis infections. J Microbiol Immunol Infect 42: 427-432.
17. Ward J, Hanna JN, Bates JR, Selvey LA (2000) Enhanced surveillance for meningococcal disease in Queensland in 1999. Commun Dis Intell 24: 332-335.
18. Noronha CP, Baran M, Nicolai CC, Azevedo MB, Bernardes AT, Monteiro GT, Lopes GR, Rodrigues Rd, Santos AM, Lemos MC (1997) Epidemiology of meningococcal disease in the city of Rio de Janeiro: changes after vaccination against B and C serogroups. Cad Saude Publica 13: 295-303.
19. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, Wenger JD, Stephens DS (1997) Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A 94: 271-276.
20. Aguilera JF, Perrocheau A, Meffre C, Hahne S (2002) Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis 8: 761-767.
21. Vogel U, Claus H, Frosch M (2000) Rapid serogroup switching in Neisseria meningitidis. N Engl J Med 342: 219-220.
22. Maiden MC, Malorny B, Achtman M (1996) A global gene pool in the neisseriae. Mol Microbiol 21: 1297-1298.
23. Linz B, Schenker M, Zhu P, Achtman M (2000) Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis. Mol Microbiol 36: 1049-1058.
24. Stovall SH and Schutze GE (2002) Meningococcal infections in children from Arkansas. Pediatr Infect Dis J 21: 366-370.
25. Brigham KSand Sandora TJ (2009) Neisseria meningitidis: epidemiology, treatment and prevention in adolescents. Curr Opin Pediatr 21: 437-443.
26. Hedberg ST, Fredlund H, Nicolas P, Caugant DA, Olcen P, Unemo M (2009) Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives. Antimicrob Agents Chemother 53: 1561-1566.